Anescribe is an iPad-based pre-operative charting application for anesthesiologists that automates patient data capture and report generation.
The App DNA
What makes this app unique?
Clinicians hire this tool to reduce administrative charting time during high-pressure surgical procedures, so the app must prove its efficiency gains outweigh the cost of manual data entry.
For Anesthesiologists and medical professionals requiring digital charting and pre-operative assessment tools on iPad.
What does it look like?
Key features
Photograph medicine bottles for instant data extraction via optical character recognition
Record vital signs and clinical notes without internet connectivity, with automatic sync upon reconnection
Hands-free note-taking using medically fluent speech-to-text
How much does it cost?
Currently free, but website references a pricing page, indicating a future transition to a paid or subscription model.
Velocity
Maintenance developmentopaqueShow more...
Anescribe has released only one version in the last 48 days, resulting in a cadence of approximately 0.14 releases per week. This frequency falls within the maintenance tier, as the single available release note is generic and lacks evidence of new features or live operations. Development appears focused on stability rather than active feature expansion or content updates.
Who built it?
Anescribe
7 apps tracked · Medical
Spanislate: Medical Spanish
Elescan
Careslate: Medical Translator
Innaslide
Thumbslate
iComprendoUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Anescribe
How's the Medical market?
Anescribe operates as a niche medical utility on iOS, holding a 5-star rating from its initial release. The lack of enterprise EHR connectivity limits its market footprint compared to integrated care-team platforms.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Anescribe
Where is it heading?
Users report: The market for clinical documentation is shifting toward integrated care-team platforms that consolidate data across hospital departments. Anescribe remains exposed to displacement by established EHR providers unless it secures data-sync partnerships that allow it to function within existing clinical workflows.
- The initial release establishes a functional offline-first charting workflow, which provides a stable foundation for future B2B integration efforts.
- The absence of enterprise EHR connectivity creates a ceiling on adoption, as hospitals prioritize systems that sync with existing patient records.
The SWOT
- OCR medicine recognition digitizes clinical history, creating high switching costs.
- Offline charting ensures clinical continuity in hospital environments lacking reliable Wi-Fi.
- Education partnerships offer untapped B2B distribution channels.
- Wearable integration could further automate vital sign capture.
Next best moves
Ship EHR integration API because it is the primary barrier to hospital-wide adoption → unlock enterprise revenue.
The counter-intuitive read
The app's current free status is a strategic liability…
Read the full takeFeature gaps
Institutional EHR integration (available in PointClickCare but absent here)
Since the last report: The analysis now accounts for a potential pivot toward subscription monetization and identifies new B2B distribution opportunities, though the core product remains in a maintenance state.
Bottom line
Anescribe succeeds as a personal productivity tool for anesthesiologists, but its lack of enterprise EHR connectivity limits its growth, so the PM should prioritize building data-sync partnerships to move from individual utility to institutional necessity.
Unlock 2 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeReport last updated